- Home
- About
- Find staff
- Ragnar Hultborn
Ragnar Hultborn
-
A Novel Method for Real-Time Quantification of Radioligand Binding to Living Tumor Cells In
Vitro
Tom Bäck, Per Albertsson, Emma Aneheim, Ragnar Hultborn, Lars Jacobsson, Sture Lindegren, Stig Palm
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS - 2024 -
Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian
cancer
Stig Palm, Tom Bäck, Emma Aneheim, Andreas Hallqvist, Ragnar Hultborn, Lars Jacobsson, H. Jensen, Sture Lindegren, Per Albertsson
Translational Oncology - 2021 -
Dark-field microscopy enhance visibility of CD31 endothelial
staining
Eva Jennische, Stefan Lange, Ragnar Hultborn
European journal of histochemistry : EJH - 2020 -
Antisecretory factor AF-16 improves vascular access to a rat mammary
tumour.
Stefan Lange, Ragnar Hultborn, Eva Jennische
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica - 2020 -
Male Breast Carcinoma after Irradiation and Long-Term Phenothiazine Exposure: A Case
Report
Ragnar Hultborn, Toshima Z Parris, Khalil Helou, Åke Borg, Shahin De Lara
Case Reports in Oncology - 2020 -
Radiosensitivity: Gender and Order of Administration of G-CSF, An Experimental Study in
Mice
Ragnar Hultborn, Per Albertsson, Susanne Ottosson, Elisabet Warnhammar, Åsa Palm, Stig Palm, Kerstin Elmroth
Radiation Research - 2019 -
Intraperitoneal alpha-Emitting Radioimmunotherapy with At-211 in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose
Estimations
Andreas Hallqvist, Karin Bergmark, Tom Bäck, Håkan Andersson, Pernilla Dahm-Kähler, Mia Johansson, Sture Lindegren, H. Jensen, Lars Jacobsson, Ragnar Hultborn, Stig Palm, Per Albertsson
Journal of Nuclear Medicine - 2019 -
Intraperitoneal Alpha-emitting Radio Immunotherapy with Astatine-211 in Relapsed Ovarian Cancer; Long-term Follow-up with Individual Absorbed Dose
Estimations.
Andreas Hallqvist, Per Albertsson, Ragnar Hultborn, Stig Palm, Karin Bergmark, Tom Bäck, Håkan Andersson, Pernilla Dahm-Kähler, Mia Johansson, Sture Lindegren, Holger Jensen, Lars Jacobsson
Journal of Medical Imaging and Radiation Sciences - 2019 -
Estimation of Long-term Risks for Cancer Induction following Adjuvant Targeted Alpha Therapy with Curative
Intent.
Stig Palm, Andreas Hallqvist, Emma Aneheim, Tom Bäck, Mia Johansson, Ragnar Hultborn, Lars Jacobsson, Sture Lindegren, Per Albertsson
Journal of Medical Imaging and Radiation Sciences - 2019 -
Blood flow, volume and arterio-venous passages in induced mammary tumours of the
rat
Ragnar Hultborn
Microvascular Research - 2018 -
Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor
Sizes.
Stig Palm, Tom Bäck, Sture Lindegren, Ragnar Hultborn, Lars Jacobsson, Per Albertsson
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2018 -
Accelerated or conventional whole brain irradiation of malignant
melanoma.
Ragnar Hultborn, Johanna Sand, Sara Kinhult, Lotta Lundgren, Ulrika Stierner, Ingela Turesson, Per Albertsson
Acta oncologica (Stockholm, Sweden) - 2017 -
Therapeutic efficacy of alpha-radioimmunotherapy with different activity levels of the Bi-213-labeled monoclonal antibody MX35 in an ovarian cancer
model
Anna Gustafsson-Lutz, Tom Bäck, Emma Aneheim, Ragnar Hultborn, Stig Palm, Lars Jacobsson, A. Morgenstern, F. Bruchertseifer, Per Albertsson, Sture Lindegren
EJNMMI Research - 2017 -
Increased absorbed liver dose in Selective Internal Radiation Therapy (SIRT) correlates with increased sphere-cluster frequency and absorbed dose
inhomogeneity
Jonas Högberg, Magnus Rizell, Ragnar Hultborn, Johanna Svensson, Olof Henrikson, Johan Mölne, Peter Gjertsson, Peter Bernhardt
EJNMMI Physics - 2015 -
IVIM reveals increased blood perfusion of liver metastases after oral intake of
Salovum®
Mikael Montelius, Oscar Gustafsson, Mats Andersson, Eva Forssell-Aronsson, Ragnar Hultborn, Susanne Ottosson, Göran Carlsson, Stefan Lange, Maria Ljungberg
2015 -
Absorbed Doses and Risk Estimates of (211)At-MX35 F(ab')2 in Intraperitoneal Therapy of Ovarian Cancer
Patients.
Elin Cederkrantz, Håkan Andersson, Peter Bernhardt, Thomas Backhaus, Ragnar Hultborn, Lars Jacobsson, Holger Jensen, Sture Lindegren, Michael Ljungberg, Tobias Magnander, Stig Palm, Per Albertsson
International journal of radiation oncology, biology, physics - 2015 -
Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version
Rebmab200.
Sture Lindegren, Luciana N S Andrade, Tom Bäck, Camila Maria L Machado, Bruno Brasil Horta, Carlos Buchpiguel, Ana Maria Moro, Oswaldo Keith Okamoto, Lars Jacobsson, Elin Cederkrantz, Kohshin Washiyama, Emma Aneheim, Stig Palm, Holger Jensen, Maria Carolina B Tuma, Roger Chammas, Ragnar Hultborn, Per Albertsson
PloS one - 2015 -
Heterogeneity of microsphere distribution in resected liver and tumour tissue following selective intrahepatic
radiotherapy
Jonas Högberg, Magnus Rizell, Ragnar Hultborn, Johanna Svensson, Olof Henrikson, Johan Mölne, Peter Gjertsson, Peter Bernhardt
EJNMMI Research - 2014 -
Differential gene expression in human fibroblasts after alpha-particle emitter (211)At compared with (60)Co
irradiation.
Anna Danielsson, Kristina Claesson, Toshima Z Parris, Khalil Helou, Szilard Nemes, Kerstin Elmroth, Jörgen Elgqvist, Holger Jensen, Ragnar Hultborn
International journal of radiation biology - 2013 -
Ex Vivo Activity Quantification in Micrometastases at the Cellular Scale Using the α-Camera
Technique.
Nicolas Chouin, Sture Lindegren, Sofia Frost, Holger Jensen, Per Albertsson, Ragnar Hultborn, Stig Palm, Lars Jacobsson, Tom Bäck
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2013 -
A new method to estimate parameters of the growth model for metastatic
tumours.
Esmaeil Mehrara, Eva Forssell-Aronsson, Viktor Johanson, Lars Kölby, Ragnar Hultborn, Peter Bernhardt
Theoretical biology & medical modelling - 2013 -
Comparison of (211)At-PRIT and (211)At-RIT of Ovarian Microtumors in a Nude Mouse
Model.
Sofia Frost, Tom Bäck, Nicolas Chouin, Ragnar Hultborn, Lars Jacobsson, Jörgen Elgqvist, Holger Jensen, Per Albertsson, Sture Lindegren
Cancer biotherapy & radiopharmaceuticals - 2013 -
Radiation exposure during liver surgery after treatment with (90)Y microspheres, evaluated with computer simulations and dosimeter
measurements.
Jonas Högberg, Magnus Rizell, Ragnar Hultborn, Johanna Svensson, Olof Henrikson, Peter Gjertsson, Peter Bernhardt
Journal of radiological protection : official journal of the Society for Radiological Protection - 2012 -
On the dose heterogeneity in normal liver tissue due to treatment of liver tumors with yttrium-90
microspheres
Jonas Högberg, Magnus Rizell, Ragnar Hultborn, Johanna Svensson, Olof Henrikson, Peter Gjertsson, Peter Bernhardt
25th Annual Congress on European Association of Nuclear Medicine, Milano, Italy, October 27-31, 2012. European Journal of Nuclear Medicine and Molecular Imaging - 2012 -
Comparison of therapeutic efficacy and biodistribution of (213)Bi- and (211)At-labeled monoclonal antibody MX35 in an ovarian cancer
model.
Anna Gustafsson, Tom Bäck, Jörgen Elgqvist, Lars Jacobsson, Ragnar Hultborn, Per Albertsson, Alfred Morgenstern, Frank Bruchertseifer, Holger Jensen, Sture Lindegren
Nuclear medicine and biology - 2012 -
Evaluation of Effects on the Peritoneum After Intraperitoneal α-Radioimmunotherapy with
(211)At.
Elin Cederkrantz, Eva Angenete, Tom Bäck, Peter Falk, Börje Haraldsson, Marie-Louise Ivarsson, Holger Jensen, Sture Lindegren, Ragnar Hultborn, Lars Jacobsson
Cancer biotherapy & radiopharmaceuticals - 2012 -
In-solution staining and arraying method for the immunofluorescence detection of γH2AX foci optimized for clinical
applications.
Pegah Johansson, Aida Muslimovic, Ragnar Hultborn, Erik Fernström, Ola Hammarsten
BioTechniques - 2011 -
The peptide AF-16 decreases high interstitial fluid pressure in solid
tumors.
Mohamed Al-Olama, Annacarin Wallgren, Bengt A. Andersson, Kliment Gatzinsky, Ragnar Hultborn, Alex Karlsson-Parra, Stefan Lange, Hans-Arne Hansson, Eva Jennische
Acta oncologica (Stockholm, Sweden) - 2011 -
In Vivo Distribution of Avidin-Conjugated MX35 and (211)At-Labeled, Biotinylated Poly-l-Lysine for Pretargeted Intraperitoneal
?-Radioimmunotherapy.
Sofia Frost, Tom Bäck, Nicolas Chouin, Holger Jensen, Ragnar Hultborn, Lars Jacobsson, Sture Lindegren
Cancer biotherapy & radiopharmaceuticals - 2011 -
RBE of <sub> α</sub>-particles from <sup>211</sup>At for complex DNA damage and cell survival in relation to cell cycle
positio.
Kristina Claesson, Karin Magnander, Helena Kahu, Sture Lindegren, Ragnar Hultborn, Kerstin Elmroth
International journal of radiation biology - 2011 -
Bremsstrahlung imaging of 90Y microspheres shows poor resemblance with distributions of 99mTc-MAA in
liver
Jonas Högberg, Magnus Rizell, Peter Gjertsson, Ragnar Hultborn, Olof Henrikson, Johanna Svensson, Peter Bernhardt
Journal of the European Society of Therapeutic Radiology and Oncology - 2010 -
Ovarian cancer: background and clinical
perspectives
Jörgen Elgqvist, Ragnar Hultborn, Sture Lindegren, Stig Palm
Targeted Radionuclide Therapy - 2010 -
Repeated Intraperitoneal alpha-Radioimmunotherapy of Ovarian Cancer in
Mice.
Jörgen Elgqvist, Håkan Andersson, Holger Jensen, Helena Kahu, Sture Lindegren, Elisabet Warnhammar Finnborg, Ragnar Hultborn
Journal of oncology - 2010 -
[Deintellectualization of the
profession].
Ragnar Hultborn
Läkartidningen - 2010 -
Clustered DNA damage in irradiated human diploid fibroblasts: influence of chromatin
organization.
Karin Magnander, Ragnar Hultborn, Kristina Claesson, Kerstin Elmroth
Radiation research - 2010 -
Preoperative radiotherapy and extracellular matrix remodeling in rectal mucosa and tumour matrix metalloproteinases and plasminogen
components.
Eva Angenete, Tom Öresland, Peter Falk, Michael Breimer, Ragnar Hultborn, Marie-Louise Ivarsson
Acta oncologica - 2009 -
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and
12-93.
Olivia Pagani, Shari Gelber, Edda Simoncini, Monica Castiglione-Gertsch, Karen N Price, Richard D Gelber, Stig B Holmberg, Diana Crivellari, John Collins, Jurij Lindtner, Beat Thürlimann, Martin F Fey, Elizabeth Murray, John F Forbes, Alan S Coates, Aron Goldhirsch, Ragnar Hultborn
Breast cancer research and treatment - 2009 -
Intraperitoneal alpha-radioimmunotherapy in mice using different specific
activities.
Jörgen Elgqvist, Håkan Andersson, Elin Haglund, Holger Jensen, Helena Kahu, Sture Lindegren, Elisabet Warnhammar Finnborg, Ragnar Hultborn
Cancer biotherapy & radiopharmaceuticals - 2009 -
Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of (211)At-MX35 F(ab')2--a phase I
study.
Håkan Andersson, Elin Cederkrantz, Tom Bäck, Chaitanya Divgi, Jörgen Elgqvist, Jakob Himmelman, György Horvath, Lars Jacobsson, Holger Jensen, Sture Lindegren, Stig Palm, Ragnar Hultborn
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2009 -
Glomerular filtration rate after alpha-radioimmunotherapy with 211At-MX35-F(ab')2: a long-term study of renal function in nude
mice.
Tom Bäck, Börje Haraldsson, Ragnar Hultborn, Holger Jensen, Martin E Johansson, Sture Lindegren, Lars Jacobsson
Cancer biotherapy & radiopharmaceuticals - 2009 -
Intraperitoneal alpha-radioimmunotherapy of ovarian cancer – pharmacokinetics and dosimetry of 211At-MX35 F(ab’)2 in a phase I
study.
E Haglund, Håkan Andersson, Tom Bäck, C Divgi, Jörgen Elgqvist, Sofia Frost, Jakob Himmelman, György Horvath, Ragnar Hultborn, Holger Jensen, Sture Lindegren, Stig Palm, Lars Jacobsson
Cancer Biotherapy and Radiopharmaceuticals - 2008 -
Intraperitoneal alpha-radioimmunotherapy of ovarian cancer – pharmacokinetics and dosimetry of 211At-MX35 F(ab’)2 in a phase I
study.
E Haglund, Håkan Andersson, Tom Bäck, C Divgi, Jörgen Elgqvist, Sofia Frost, Jakob Himmelman, György Horvath, Ragnar Hultborn, Holger Jensen, Sture Lindegren, Stig Palm, Lars Jacobsson
Radiotherapy and Oncology - 2008 -
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast
cancer.
A Ravaioli, F Monti, M M Regan, F Maffini, M G Mastropasqua, V Spataro, M Castiglione-Gertsch, I Panzini, L Gianni, A Goldhirsch, A Coates, K N Price, B A Gusterson, G Viale, Ragnar Hultborn, Arne Wallgren
Annals of oncology - 2008 -
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast
cancer.
G Gruber, B F Cole, M Castiglione-Gertsch, Stig B Holmberg, J Lindtner, R Golouh, J Collins, D Crivellari, B Thürlimann, E Simoncini, M F Fey, R D Gelber, A S Coates, K N Price, A Goldhirsch, G Viale, B A Gusterson, Ragnar Hultborn
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO - 2008 -
Liposarcoma: outcome based on the Scandinavian Sarcoma Group
register.
Katarina Engström, Peter Bergh, Pelle Gustafson, Ragnar Hultborn, Helena Johansson, Rickard Löfvenberg, Olga Zaikova, Clement Trovik, Ola Wahlstr?m, Henrik C F Bauer
Cancer - 2008 -
Chromosomal damage in two X-ray irradiated cell lines: influence of cell cycle stage and irradiation
temperature
D. E. Larsson, Staffan Gustavsson, Ragnar Hultborn, J. Nygren, Ulla Delle, Kerstin Elmroth
Anticancer Research - 2007 -
Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like
morphology.
Katarina Engström, Peter Bergh, C. G. Cederlund, Ragnar Hultborn, Helena Willen, Pierre Åman, Lars-Gunnar Kindblom, Jeanne Meis-Kindblom
Acta oncologica (Stockholm, Sweden) - 2007 -
Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude
mice.
Stig Palm, Tom Bäck, Ingela Claesson, Anna Danielsson, Jörgen Elgqvist, Sofia Frost, Ragnar Hultborn, Holger Jensen, Sture Lindegren, Lars Jacobsson
International journal of radiation oncology, biology, physics - 2007 -
Biodistribution of free 225Ac in nude
mice.
Stig Palm, Tom Bäck, Jörgen Elgqvist, Ragnar Hultborn, Helena Kahu, Sture Lindegren, Elisabet Warnhammar, Lars Jacobsson
Cancer Biotherapy and Radiopharmaceuticals - 2006 -
Pharmacokinetics and dosimetry of 211At-MX35 F(ab')2 in therapy of ovarian cancer - preliminary results from an ongoing phase I
study.
Ragnar Hultborn, Håkan Andersson, Tom Bäck, C Divgi, Jörgen Elgqvist, Jakob Himmelman, György Horvath, Holger Jensen, Sture Lindegren, Stig Palm, Lars Jacobsson
Cancer Biotherapy and Radiopharmaceuticals - 2006 -
Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35
F(ab')2.
Jörgen Elgqvist, Håkan Andersson, Peter Bernhardt, Tom Bäck, Ingela Claesson, Ragnar Hultborn, Holger Jensen, Bengt R Johansson, Sture Lindegren, Marita Olsson, Stig Palm, Elisabet Warnhammar Finnborg, Lars Jacobsson
International journal of radiation oncology, biology, physics - 2006 -
Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: Outcome related to measured tumor size and mean absorbed
dose.
Jörgen Elgqvist, Håkan Andersson, Tom Bäck, Ingela Claesson, Ragnar Hultborn, Holger Jensen, Bengt R Johansson, Sture Lindegren, Marita Olsson, Stig Palm, Elisabet Warnhammar Finnborg, Lars Jacobsson
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2006 -
Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab')2: therapeutic efficacy and
myelotoxicity
Jörgen Elgqvist, Håkan Andersson, Tom Bäck, Ingela Claesson, Ragnar Hultborn, H. Jensen, Sture Lindegren, Marita Olsson, Stig Palm, Elisabet Warnhammar Finnborg, Lars Jacobsson
Nucl Med Biol - 2006 -
TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast
cancer
K. Villman, J. Sjostrom, R. Heikkila, Ragnar Hultborn, P. Malmstrom, N. O. Bengtsson, M. Soderberg, E. Saksela, C. Blomqvist
Acta Oncol - 2006 -
Alpha-particle emitter [211At] mediated anticancer efficacy of Trastuzumab: Single-dose and fractionated 211At-Herceptin therapy in a nude mouse ovarian carcinoma
model.
Stig Palm, Tom Bäck, Ingela Claesson, Jörgen Elgqvist, Ragnar Hultborn, Börje Karlsson, Sture Lindegren, Lars Jacobsson
Journal of Nuclear Medicine - 2005 -
Early disturbance of microvascular function precedes chemotherapy-induced intestinal
injury
Edvard Abel, Tor Ekman, Elisabet Warnhammar Finnborg, Ragnar Hultborn, Eva Jennische, Stefan Lange
Dig Dis Sci - 2005 -
211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in
vivo
Tom Bäck, Håkan Andersson, C. R. Divgi, Ragnar Hultborn, H. Jensen, Sture Lindegren, Stig Palm, Lars Jacobsson
J Nucl Med - 2005 -
Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody
MX35
Jörgen Elgqvist, Håkan Andersson, Tom Bäck, Ragnar Hultborn, H. Jensen, Börje Karlsson, Sture Lindegren, Stig Palm, Elisabet Warnhammar Finnborg, Lars Jacobsson
J Nucl Med - 2005 -
Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude
mice
Jörgen Elgqvist, Peter Bernhardt, Ragnar Hultborn, H. Jensen, Börje Karlsson, Sture Lindegren, Elisabet Warnhammar Finnborg, Lars Jacobsson
J Nucl Med - 2005 -
Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy
Group
B. Glimelius, O. Dahl, B. Cedermark, A. Jakobsen, S. M. Bentzen, H. Starkhammar, H. Gronberg, Ragnar Hultborn, M. Albertsson, L. Pahlman, K. M. Tveit
Acta Oncol - 2005 -
Antitumor effect of At-211-radioimmunotherapy on subcutaneous human ovarian cancer xenografts: Evaluation of RBE of an alpha emitter in
vivo.
Tom Bäck, Stig Palm, Sture Lindegren, Börje Karlsson, Ragnar Hultborn, Lars Jacobsson
Cancer Biotherapy and Radiopharmaceuticals - 2004 -
Existential pain--an entity, a provocation, or a
challenge?
P. Strang, Susann Strang, Ragnar Hultborn, S. Arner
J Pain Symptom Manage - 2004 -
Astatine-211-labeled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumor
model
Håkan Andersson, Jörgen Elgqvist, György Horvath, Ragnar Hultborn, Lars Jacobsson, H. Jensen, Börje Karlsson, Sture Lindegren, Stig Palm
Clin Cancer Res - 2003 -
Single-cell irradiation from [211At] astatine-labeled C215 monoclonal antibody: improved estimates of radiosensitivity from measurements on cellular uptake and
retention
Stig Palm, Tom Bäck, Ingela Claesson, Ulla Delle, Ragnar Hultborn, Sture Lindegren, Lars Jacobsson
Anticancer Res - 2003 -
(211)At-labeled and biotinylated effector molecules for pretargeted radioimmunotherapy using poly-L- and poly-D-Lysine as
multicarriers
Sture Lindegren, Börje Karlsson, Lars Jacobsson, Håkan Andersson, Ragnar Hultborn, G. Skarnemark
Clin Cancer Res - 2003 -
Chromatin- and temperature-dependent modulation of radiation-induced double-strand
breaks
Kerstin Elmroth, J. Nygren, B. Stenerlow, Ragnar Hultborn
Int J Radiat Biol - 2003 -
At-211 labelled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumour
model.
Ragnar Hultborn, Håkan Andersson, Tom Bäck, Ingela Claesson, Ulla Delle, Jörgen Elgqvist, György Horvath, Lars Jacobsson, Holger Jensen, Sture Lindegren, Stig Palm, Elisabet Warnhammar Finnborg
Cancer Biotherapy and Radiopharmaceuticals - 2002 -
Comparison of hematological toxicity of the alpha emitter 211At and the electron emitter 99mTc in nude
mice.
Jörgen Elgqvist, Peter Bernhardt, Ragnar Hultborn, Börje Karlsson, Sture Lindegren, Stig Palm, Lars Jacobsson
Cancer Biotherapy and Radiopharmaceuticals - 2002 -
Physical performance, toxicity, and quality of life as assessed by the physician and the
patient
M. L. Luoma, L. Hakamies-Blomqvist, J. Sjostrom, H. Mouridsen, A. Pluzanska, P. Malmstrom, N. O. Bengtsson, Ragnar Hultborn, B. Ostenstaad, I. Mjaaland, V. Valvere, E. Wist, G. Baldursson, J. Ahigren, C. Blomqvist
Acta Oncol - 2002 -
Exploring the anticancer potential of the alpha-particle emitter
astatine-211.
Stig Palm, Håkan Andersson, Tom Bäck, Ingela Claesson, Ulla Delle, György Horvath, Ragnar Hultborn, Lars Jacobsson, Börje Karlsson, Sture Lindegren
Anticancer Research - 2001 -
Bone marrow micrometastases in patients with stage I-II localised prostate
cancer
V. Vagunda, Karl Landys, J. P. Kankkunen, M. Vagundova, Ragnar Hultborn, J. Kovarik, Jonas Hugosson
Eur J Cancer - 2001 -
Hypothermic modulation of doxorubicin, cisplatin and radiation cytotoxicity in
vitro
L. Lundgren-Eriksson, Ragnar Hultborn, R. Henriksson
Anticancer Res - 2001 -
Radio-and chemotoxicity in mice during
hypothermia
L. Lundgren-Eriksson, Åsa Palm, Walter Ryd, Elisabet Warnhammar Finnborg, Ragnar Hultborn
Anticancer Res - 2001 -
The diagnosis of cancer in the "roar" of potential cancer symptoms of patients in primary health care. Research by means of the computerised
journal
J. Mansson, B. Marklun, Ragnar Hultborn
Scand J Prim Health Care - 2001 -
In vitro effects and microdosimetry of 211At for tumour
therapy.
Stig Palm, Håkan Andersson, Tom Bäck, Ingela Claesson, Ulla Delle, Ragnar Hultborn, Lars Jacobsson, Istvan Köpf, Sture Lindegren
International Journal of Radiation Oncology, Biology, Physics - 2000 -
In vitro effects of free 211At,211At-albumin and 211At-monoclonal antibody compared to external photon irradiation on two human cancer cell
lines
Stig Palm, Håkan Andersson, Tom Bäck, Ingela Claesson, Ulla Delle, Ragnar Hultborn, Lars Jacobsson, Istvan Köpf, Sture Lindegren
Anticancer Res - 2000 -
Cell growth kinetics of the human cell line Colo-205 irradiated with photons and astatine-211
alpha-particles
Stig Palm, Håkan Andersson, Tom Bäck, Ingela Claesson, Ulla Delle, Ragnar Hultborn, Lars Jacobsson, Istvan Köpf, Sture Lindegren
Anticancer Res - 2000 -
Radiation-induced double-strand breaks in mammalian DNA: influence of temperature and
DMSO
Kerstin Elmroth, J. Nygren, L. J. Erkell, Ragnar Hultborn
Int J Radiat Biol - 2000 -
Effect of hypothermic irradiation of the growth characteristics of two human cell
lines
Kerstin Elmroth, J. Nygren, Lars Johan Erkell, Ragnar Hultborn
Anticancer Res - 2000 -
Influence of temperature on radiation-induced inhibition of DNA
supercoiling
Kerstin Elmroth, L. J. Erkell, Ragnar Hultborn
Radiat Res - 1999 -
Radiation and hypothermia: changes in DNA supercoiling in human diploid
fibroblasts
Kerstin Elmroth, L. J. Erkell, J. Nygren, Ragnar Hultborn
Anticancer Res - 1999 -
Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter
study
Ragnar Hultborn, S. Gundersen, S. Ryden, E. Holmberg, J. Carstensen, U. B. Wallgren, S. Killany, L. Andreassen, G. Carlsson, N. Fahl, T. Hatschek, H. H. Sommer, Y. Hessman, B. Hornmark-Stenstam, S. Johnsborg, R. Klepp, R. Laino, L. G. Niklasson, Carl-Magnus Rudenstam, A. Sundbeck, M. Soderberg, G. Tejler
Anticancer Res - 1999 -
Acute hematologic feasibility of G-CSF supported dose-escalated FEC therapy as adjuvant treatment after breast cancer
surgery
Susanne Ottosson, Karin Magnusson, Ragnar Hultborn
Anticancer Res - 1999 -
Symptom pattern and diagnostic work-up of malignancy at first symptom presentation as related to level of care. A retrospective study from the primary health care centre area of Kungsbacka,
Sweden
J. Mansson, C. Bjorkelund, Ragnar Hultborn
Neoplasma - 1999 -
Effects of the alpha-particle emitter At-211 and low-dose-rate gamma-radiation on the human cell line Colo-205 as studied with a growth
assay
Stig Palm, Tom Bäck, Ingela Claesson, Ulla Delle, Ragnar Hultborn, Lars Jacobsson, Istvan Köpf, Sture Lindegren
Anticancer Res - 1998 -
Effects of suramin on polyamine metabolism in B16 murine melanoma
cells
Amel Gritli Linde, U. Bjorkman, Ulla Delle, L. Frostesjo, Ragnar Hultborn, K. Hulten, Bengt R Johansson, Ulf Nannmark, A. Linde
Anticancer Res - 1998 -
Opposing effects of suramin and DL-alpha-difluoromethylornithine on polyamine metabolism contribute to a synergistic action on B16 melanoma cell growth in
vitro
Amel Gritli Linde, U. Bjorkman, Ulla Delle, Ragnar Hultborn, B. R. Johansson, Ulf Nannmark, A. Linde
Anticancer Res - 1998 -
Growth and clonogenic assays compared for irradiated MCF-7 and Colo-205 cell
lines
Y. Y. Yang, M. Olofsson, Istvan Köpf, Ragnar Hultborn
Anticancer Res - 1998 -
Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median
follow-up
Karl Landys, S. Persson, J. Kovarik, Ragnar Hultborn, E. Holmberg
Breast Cancer Res Treat - 1998 -
Prevalence of Klinefelter's syndrome in male breast cancer
patients
Ragnar Hultborn, C. Hanson, Istvan Köpf, I. Verbiene, Elisabet Warnhammar Finnborg, Anna Weimarck
Anticancer Res - 1997 -
Prolonged activation of soleus motoneurones following a conditioning train in soleus Ia afferents - A case for a reverberating
loop?
Ragnar Hultborn, Holger Wigström, Bo Wängberg
Neuroscience letters - 1975